3D cell culture developer looks to expand US footprint

Australia company, Inventia Life Science, which is focused on advanced 3D cell cultures for research and clinical purposes, has just closed a US$25M Series B funding round, led by Blackbird Ventures.

Related Keywords

Sydney ,New South Wales ,Australia ,Niki Scevak ,Julio Ribeiro ,Dwayne Dexter , ,Skip Capital ,Blackbird Ventures ,Markets Amp Regulations ,Analytical Technologies Amp Services ,Cell Culture ,Drug Discovery ,